-
Results That Matter
Cancer medications granted accelerated approval are often confirmed despite not demonstrating a benefit in overall survival or quality of life.
by Eric Fitzsimmons
-
April 5: The Week in Cancer News
More cancer patients are enrolling in clinical trials, and sentinel node biopsies alone may be adequate for some early-stage breast cancers.
by Marci A. Landsmann
-
Genetic Testing for Women With Breast Cancer
New recommendations clarify when women diagnosed with breast cancer should be offered genetic testing for inherited cancer risk.
by Laura Gesualdi-Gilmore
-
March 29: The Week in Cancer News
Survival rates have increased for older AML patients who receive stem cell transplants, and cervical cancer diagnoses rise among women living in low-income counties.
by Kevin McLaughlin
-
TIL Therapy Amplifies the Immune System’s Attack on Melanoma
The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
by Sandra Gordon
-
March 22: The Week in Cancer News
First CAR T-cell therapy approval in chronic lymphocytic leukemia, and Environmental Protection Agency announces a complete ban on asbestos use in manufacturing.
by Thomas Celona
-
Dealing With Immediate Medical Test Results
Patients have been entitled to immediate access to medical records and test results for three years as a result of the Cures Act. It has changed how patients and doctors share information.
by Taneia Surles
-
March 15: The Week in Cancer News
Modified CAR T-cell therapy shows promise in glioblastoma, and an immunotherapy may soon be available as an injection.
by Eric Fitzsimmons
-
Empowering Pediatric Cancer Patients
After twice being treated for leukemia as a child, Brady Lucas discusses the mental impact of pediatric cancer.
by Suzanne McBride
-
March 8: The Week in Cancer News
Why do many Asian American women who have never smoked have lung cancer, and a report finds acne products can create cancer-causing benzine.
by Marci A. Landsmann
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff